Showing results (51-60 of 871) with videos related to

Sort By:
Pageof 88
Journal of the Neurological Sciences|March 26, 2013
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseasesViktoria Gredler, Simone Mader, Kathrin Schanda, et al.
Current Opinion in Neurology|February 22, 2018
Mechanisms for lesion localization in neuromyelitis optica spectrum disordersMonika Bradl, Markus Reindl, Hans Lassmann
Physiotherapy|October 2, 2022
Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic reviewBarbara Seebacher, Markus Reindl, Turhan Kahraman
Expert Review of Molecular Diagnostics|March 27, 2024
Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disordersAngelika Bauer, Harald Hegen, Markus Reindl
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 2, 2023
The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic PathwayMagdalena Lerch, Angelika Bauer, Markus Reindl
Journal of Neuroinflammation|July 3, 2016
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disordersFriederike Tuller, Hannah Holzer, Kathrin Schanda, et al.
Plos One|August 2, 2019
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosisRainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, et al.
Journal of Neurology|March 6, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSFJens Kuhle, Raija L P Lindberg, Axel Regeniter, et al.
Pageof 88